Analysis of functional urological surgery trends 2013-2024 in England using the HES database.

World journal of urology 2026 Vol.44(1) p. 96

Spazzapan M, Evans R, Mehta S, Malde S, Sahai A

관련 도메인

Abstract

[OBJECTIVE] To review recent trends in common functional urology surgery in England, using the Hospital Episode Statistics (HES) database.

[PATIENTS AND METHODS] Data between 2013 and 2024 were obtained from the HES database, a publicly available dataset recording details about procedures in NHS England. We recorded the procedures for treatment of female stress urinary incontinence (SUI), urgency urinary incontinence (UUI), post-prostatectomy incontinence (PPI), vesicovaginal fistula (VVF) and benign prostatic enlargement (BPE) surgery.

[RESULTS] Early in the study period, the most common procedures for SUI were insertion of transobturator and tension-free vaginal tape (8319 procedures/year). We observe an almost complete halt in tape insertion and an increase in removal from 2019 (8 procedures/year), due to concerns about complications and the 'mesh pause' in the UK. Injection of bulking agents became the mainstream treatment from 2019 (2490 procedures/year). For refractory UUI, intravesical Botulinum toxin A (BTX) remains the preferred treatment modality (9842 procedures/year). No significant increases in neuromodulation were observed (762/year), and numbers remain low for ileocystoplasty (100/year). Transurethral Resection of the Prostate (TURP) remains the commonest operation for BPE with 15,579 cases in 2023-2024. Laser resection modalities (Holmium laser Enucleation, or HoLEP, and Photoselective Vaporization of the Prostate, or PVP) saw increases with 5098 cases in 2023-2024. VVF repair numbers remain low, averaging 83 per year. There was a reduction in overall surgical numbers during the COVID-19 pandemic, with a partial recovery from 2022 onwards.

[CONCLUSION] Due to concerns around tape-related complications, bulking agents are now the mainstream treatment of SUI in women, and BTX in UUI. Whilst the use of laser is becoming increasingly popular, TURP remains the commonest procedure performed for BPE. There has only been a partial recovery in surgical numbers following the pandemic.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
합병증 vesicovaginal fistula scispacy 1
합병증 ileocystoplasty ( scispacy 1
약물 8319 scispacy 1
약물 Holmium C0019846
holmium
scispacy 1
약물 SUI → stress urinary incontinence C0042025
Urinary Stress Incontinence
scispacy 1
약물 [OBJECTIVE] scispacy 1
약물 urinary scispacy 1
약물 PVP scispacy 1
약물 COVID-19 scispacy 1
질환 stress urinary incontinence C0042025
Urinary Stress Incontinence
scispacy 1
질환 SUI → stress urinary incontinence C0042025
Urinary Stress Incontinence
scispacy 1
질환 urinary incontinence C0042024
Urinary Incontinence
scispacy 1
질환 UUI → urgency urinary incontinence C0150045
Urge Incontinence
scispacy 1
질환 incontinence C0021167
Incontinence
scispacy 1
질환 fistula C0016169
pathologic fistula
scispacy 1
질환 VVF → vesicovaginal fistula C0042582
Vesicovaginal Fistula
scispacy 1
질환 prostatic enlargement C0426732
Large prostate
scispacy 1
질환 BPE → benign prostatic enlargement C1704272
Benign Prostatic Hyperplasia
scispacy 1
질환 Prostate C0033572
Prostate
scispacy 1
질환 15,579 scispacy 1
질환 tape-related complications scispacy 1
질환 urological scispacy 1
질환 NHS scispacy 1
질환 benign prostatic scispacy 1
질환 BTX → Botulinum toxin A scispacy 1
질환 TURP → Transurethral Resection of the Prostate scispacy 1
기타 HES → Hospital Episode Statistics scispacy 1
기타 female scispacy 1
기타 UUI → urgency urinary incontinence scispacy 1
기타 VVF → vesicovaginal fistula scispacy 1
기타 women scispacy 1
기타 BTX → Botulinum toxin A scispacy 1

MeSH Terms

Humans; Female; Urologic Surgical Procedures; Databases, Factual; England; Male; Urinary Incontinence, Stress

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문